Abstract
Corticotropin releasing factor (CRF) receptors belong to the secretin family of G proteincoupled receptors (GPCRs) and are responsible for initiating endocrine stress responses and mediating anxiety related behaviors upon activation via stressors. The main binding site for the CRF ligands is the first extracellular domain (ECD) of the receptors. Several structures of ligand-free and ligand-bound ECDs were recently determined either by nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography. They reveal how the ligands bind through both hydrophobic and hydrophilic interactions to the ECDs, which is highly dynamic in the absence of ligands. It is the purpose of this review to discuss these structures with a particular focus on ligand-receptor interaction.
Keywords: GPCR, CRF receptors, first extracellular domain, structure, ligand binding, ECD.
Current Molecular Pharmacology
Title:Structures of the First Extracellular Domain of CRF Receptors
Volume: 10
Author(s): Viviane Zelenay, Marilyn Perrin and Roland Riek*
Affiliation:
- Department of Physical Chemistry, ETH Zurich, Vladimir-Prelog-Weg 2, 8093 Zurich,Switzerland
Keywords: GPCR, CRF receptors, first extracellular domain, structure, ligand binding, ECD.
Abstract: Corticotropin releasing factor (CRF) receptors belong to the secretin family of G proteincoupled receptors (GPCRs) and are responsible for initiating endocrine stress responses and mediating anxiety related behaviors upon activation via stressors. The main binding site for the CRF ligands is the first extracellular domain (ECD) of the receptors. Several structures of ligand-free and ligand-bound ECDs were recently determined either by nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography. They reveal how the ligands bind through both hydrophobic and hydrophilic interactions to the ECDs, which is highly dynamic in the absence of ligands. It is the purpose of this review to discuss these structures with a particular focus on ligand-receptor interaction.
Export Options
About this article
Cite this article as:
Zelenay Viviane, Perrin Marilyn and Riek Roland*, Structures of the First Extracellular Domain of CRF Receptors, Current Molecular Pharmacology 2017; 10 (4) . https://dx.doi.org/10.2174/1874467210666170110120301
DOI https://dx.doi.org/10.2174/1874467210666170110120301 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Conductance and Resistance Vessels in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cyclic Opioid Peptides
Current Medicinal Chemistry Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics
Current Topics in Medicinal Chemistry From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Memory Enhancing Effect of Black Pepper in the AlCl3 Induced Neurotoxicity Mouse Model is Mediated Through Its Active Component Chavicine
Current Pharmaceutical Biotechnology Isoniazid: Metabolic Aspects and Toxicological Correlates
Current Drug Metabolism Induction of Labour for Maternal Request: An Observational Study of Maternal and Fetal Outcomes
Reviews on Recent Clinical Trials Bispidine as a Privileged Scaffold
Current Topics in Medicinal Chemistry α-Synuclein Aggregation
Protein & Peptide Letters Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways
Current Neurovascular Research Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity
Drug Metabolism Letters Use of fMRI and Structural Equation Modeling for Studying Interconnected Brain Areas within a Hypothetical Network
Current Medical Imaging Bone Regeneration and Repair
Current Stem Cell Research & Therapy The Metabolism of Anthocyanins
Current Drug Metabolism Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Current Neuropharmacology Serotonin7 Receptors (5-HT7Rs)and their Ligands
Current Medicinal Chemistry Subject Index to Volume 4
Current Medicinal Chemistry - Central Nervous System Agents